Article Name Global/International

U.S. FDA Grants Breakthrough Device Designation to Artera’s AI-Powered Prostate Cancer Decision Support Tool

Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients.

10th July, 2025


Mann Eye Institute Unveils Pioneering Treatment for Dry AMD

New Therapeutic Breakthrough Offers Hope for Patients with Geographic Atrophy, the Advanced Form of Dry Age-Related Macular Degeneration

10th July, 2025


Medtronic Treats First Patient in SPYRAL GEMINI Multi-Organ Pilot Study

Study to Evaluate Renal Denervation Therapy’s Potential Benefits Beyond Hypertension Across Multiple Organ Systems

10th July, 2025


Companion Spine to Acquire Paradigm Spine GmbH and Coflex®, CoFix® Implant Assets from Xtant Medical

Strategic Acquisition Expands Companion Spine’s Portfolio in Motion-Preserving, Minimally Invasive Spine Therapies

09th July, 2025


Rain Eye Drops Launches First-Ever Dispenser Aid for Single-Use Eye Drops

Innovative Device Enhances Ease, Precision, and Accessibility for Patients Using Preservative-Free Eye Medications

09th July, 2025


Eko CORE 500® Wins Red Dot Design Award for Product Innovation

Next-Generation Digital Stethoscope Recognized for Excellence in Design, Usability, and Clinical Impact

09th July, 2025


Cochlear Unveils World’s First Smart Cochlear Implant System

Revolutionary Implant Integrates Sensor-Driven Technology and Cloud Connectivity to Enhance Hearing Outcomes and Patient Monitoring

09th July, 2025


JenaValve Showcases Live Trilogy™ THV Implant Procedures at New York Valves 2025

Breakthrough transcatheter aortic valve technology for aortic regurgitation and stenosis featured in front of global clinical audience during premier interventional cardiology event.

08th July, 2025


MicroGenDX Revolutionizes Infectious Disease Detection with 24-Hour NGS Testing Platform

Pioneering next-generation sequencing technology delivers rapid, accurate pathogen identification to accelerate targeted treatment and improve patient outcomes across clinical settings.

08th July, 2025


Boston Scientific Secures FDA Approval for Expanded Labeling of FARAPULSE™ PFA System

Milestone enhances clinical use of the FARAPULSE™ Pulsed Field Ablation platform for treatment of atrial fibrillation, strengthening its role in next-generation cardiac electrophysiology.

08th July, 2025


Alcon to Acquire LumiThera, Expanding Retinal Portfolio with Breakthrough AMD Therapy

Acquisition adds FDA-cleared Valeda® Light Delivery System to Alcon’s pipeline, targeting early and intermediate dry age-related macular degeneration through photobiomodulation technology

08th July, 2025


Morphic Medical Secures CE Mark for RESET® Endoscopic Therapy Device

Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe.

08th July, 2025


BioNxt Advances Sublingual Cladribine Program Toward Next Phase for MS Treatment

Innovative thin-film formulation of cladribine moves forward as BioNxt prepares for next-stage development in multiple sclerosis therapy, aiming to enhance patient convenience and treatment adherence.

07th July, 2025


Major U.S. Healthcare System Expands Sectra Partnership to Include Pathology Imaging

Enterprise Imaging Cloud Now Integrates Pathology for Streamlined Cancer Diagnostics and Cross-Disciplinary Collaboration

07th July, 2025


CELFULL Launches Celfavor NADH Microcapsules, Redefining Anti-Aging Innovation

New microencapsulation technology ensures NADH stability and absorption, setting a new benchmark in cellular health and longevity supplements.

07th July, 2025


ReCerf Receives CE Mark, Expanding Access to Advanced Hip Resurfacing in Europe

Ceramic-based hip resurfacing implant gains European regulatory approval, offering patients a bone-preserving, metal-free alternative for hip joint restoration.

04th July, 2025


Thermo Fisher’s NGS-Based Oncomine Dx Express Test Gains FDA Approval

FDA clears assay as companion diagnostic for ZEGFROVY™ and broad tumor profiling, advancing precision oncology diagnostics.

04th July, 2025


Philips Secures FDA Clearance for SmartSpeed Precise, Advancing MRI Speed and Image Precision

Dual AI-Powered Imaging Software Set to Enhance Diagnostic Confidence and Workflow Efficiency in MRI

03rd July, 2025


Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer